Drug Profile
GLPG 0555
Alternative Names: GLPG 555; GLPG0555Latest Information Update: 11 Aug 2022
Price :
$50
*
At a glance
- Originator Galapagos NV
- Developer Galapagos NV; GSK
- Class Disease-modifying antirheumatics; Small molecules
- Mechanism of Action Protein kinase modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Discontinued Osteoarthritis